Drug price regulation based on the principles of the social market economy : part 2 / Schlander, Michael; Jaecker, Andreas; Voelkl, Martin
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Die pharmazeutische Industrie - 75(2013), 4, Seite 589-594 |
| Sprache: |
Deutsch |
|---|
| Beteiligte Personen: |
Schlander, Michael, 1959- [VerfasserIn] |
|---|
| Umfang: |
6 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1632194090 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | 1632194090 | ||
| 003 | DE-627 | ||
| 005 | 20230426172111.0 | ||
| 007 | tu | ||
| 008 | 130709s2013 xx ||||| 00| ||ger c | ||
| 035 | |a (DE-627)1632194090 | ||
| 035 | |a (DE-576)389583162 | ||
| 035 | |a (DE-599)BSZ389583162 | ||
| 035 | |a (OCoLC)1341055117 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Schlander, Michael |d 1959- |e verfasserin |0 (DE-588)1036904652 |0 (DE-627)751411957 |0 (DE-576)389587710 |4 aut | |
| 245 | 1 | 0 | |a Drug price regulation based on the principles of the social market economy |b part 2 |c Schlander, Michael; Jaecker, Andreas; Voelkl, Martin |
| 264 | 1 | |c 2013 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Jäcker, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Völkl, Martin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Die pharmazeutische Industrie |d Aulendorf : Editio-Cantor-Verl. für Medizin und Naturwiss., 1934 |g 75(2013), 4, Seite 589-594 |w (DE-627)129547891 |w (DE-600)218664-0 |w (DE-576)014999242 |x 0031-711X |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2013 |g number:4 |g pages:589-594 |g extent:6 |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ILN_2013 | ||
| 912 | |a ISIL_DE-16-250 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_26 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_118 | ||
| 912 | |a GBV_ILN_164 | ||
| 912 | |a GBV_ILN_252 | ||
| 912 | |a GBV_ILN_267 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_2008 | ||
| 912 | |a GBV_ILN_2012 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_2116 | ||
| 912 | |a GBV_ILN_2149 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4247 | ||
| 912 | |a GBV_ILN_4256 | ||
| 912 | |a GBV_ILN_4305 | ||
| 936 | u | w | |d 75 |j 2013 |e 4 |h 589-594 |g 6 |
| 951 | |a AR | ||
| 952 | |d 75 |j 2013 |e 4 |h 589-594 |g 6 | ||
| 980 | |2 2013 |1 01 |x DE-16-250 |b 328397442X |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 09-07-13 | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2013 | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_3 | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_6 | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1459593464 |a Schlander, Michael | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416469354 |a Mannheimer Institute für Public Health (MIPH) | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_1 | ||